⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

Official Title: A Phase III Trial to Compare the Safety and Efficacy of Lapatinib Plus Trastuzumab Plus an Aromatase Inhibitor (AI) vs. Trastuzumab Plus an AI vs. Lapatinib Plus an AI as 1st- or 2nd- Line Therapy in Postmenopausal Subjects With Hormone Receptor+, HER2-positive Metastatic Breast Cancer (MBC) Who Received Prior Trastuzumab and Endocrine Therapies

Study ID: NCT01160211

Study Description

Brief Summary: A study to compare the safety and efficacy of an aromatase inhibitor in combination with lapatinib, trastuzumab or both for the treatment of hormone receptor positive, HER2+ metastatic breast cancer (MBC).

Detailed Description: This was a Phase III, randomized, open-label, multi-center, three arm study of lapatinib plus trastuzumab plus an aromatase inhibitor (AI), trastuzumab plus an AI, or lapatinib plus an AI to evaluate the efficacy and safety of these regimens as first- or second-line therapy in postmenopausal subjects with hormone receptor positive (HR+), HER2-positive metastatic breast cancer (MBC) who have received prior trastuzumab and endocrine therapies. Eligible subjects was postmenopausal; had tumors that are ER and/or PgR positive and HER2-positive; had Stage IV metastatic breast cancer. The primary objective was to demonstrate superiority of lapatinib/trastuzumab/AI combination versus (vs.) trastuzumab/AI combination for progression free survival. The secondary objectives were to evaluate progression free survival in trastuzumab/AI vs. lapatinib/AI and trastuzumab/lapatinib/AI vs. lapatinib/AI, overall survival, overall response rate, clinical benefit rate, the safety and tolerability of all three treatment groups (lapatinib plus trastuzumab plus an AI, trastuzumab plus an AI, or lapatinib plus an AI), and quality of life status relative to baseline.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Novartis Investigative Site, La Jolla, California, United States

Novartis Investigative Site, Pleasant Hill, California, United States

Novartis Investigative Site, Hollywood, Florida, United States

Novartis Investigative Site, Miami, Florida, United States

Novartis Investigative Site, Augusta, Georgia, United States

Novartis Investigative Site, Lawrenceville, Georgia, United States

Novartis Investigative Site, Chicago, Illinois, United States

Novartis Investigative Site, Goshen, Indiana, United States

Novartis Investigative Site, Waterloo, Iowa, United States

Novartis Investigative Site, Grand Rapids, Michigan, United States

Novartis Investigative Site, Minneapolis, Minnesota, United States

Novartis Investigative Site, Billings, Montana, United States

Novartis Investigative Site, Omaha, Nebraska, United States

Novartis Investigative Site, Albuquerque, New Mexico, United States

Novartis Investigative Site, Albuquerque, New Mexico, United States

Novartis Investigative Site, Cary, North Carolina, United States

Novartis Investigative Site, Dayton, Ohio, United States

Novartis Investigative Site, Germantown, Tennessee, United States

Novartis Investigative Site, Houston, Texas, United States

Novartis Investigative Site, Tacoma, Washington, United States

Novartis Investigative Site, Milwaukee, Wisconsin, United States

Novartis Investigative Site, Berazategui, Buenos Aires, Argentina

Novartis Investigative Site, Capital Federal, Buenos Aires, Argentina

Novartis Investigative Site, Ciudad Aut6noma de Buenos Aires, Buenos Aires, Argentina

Novartis Investigative Site, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

Novartis Investigative Site, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

Novartis Investigative Site, La Plata, Buenos Aires, Argentina

Novartis Investigative Site, Viedma, Río Negro, Argentina

Novartis Investigative Site, Rosario, Santa Fe, Argentina

Novartis Investigative Site, Ciudad Autonoma de Buenos Aires, , Argentina

Novartis Investigative Site, Cordoba, , Argentina

Novartis Investigative Site, La Rioja, , Argentina

Novartis Investigative Site, Quilmes, , Argentina

Novartis Investigative Site, San Miguel de Tucuman, , Argentina

Novartis Investigative Site, Box Hill, Victoria, Australia

Novartis Investigative Site, Wodonga, Victoria, Australia

Novartis Investigative Site, Adelaide, , Australia

Novartis Investigative Site, Douglas, , Australia

Novartis Investigative Site, Ringwood East, , Australia

Novartis Investigative Site, Tweed Heads, , Australia

Novartis Investigative Site, Leuven, , Belgium

Novartis Investigative Site, Liege, , Belgium

Novartis Investigative Site, Namur, , Belgium

Novartis Investigative Site, Fortaleza, Ceará, Brazil

Novartis Investigative Site, Goiania, Goiás, Brazil

Novartis Investigative Site, Porto Alegre, Rio Grande Do Sul, Brazil

Novartis Investigative Site, Porto Alegre, Rio Grande Do Sul, Brazil

Novartis Investigative Site, Barretos, São Paulo, Brazil

Novartis Investigative Site, Sao Paulo, São Paulo, Brazil

Novartis Investigative Site, Sao Paulo, São Paulo, Brazil

Novartis Investigative Site, Sao Paulo, São Paulo, Brazil

Novartis Investigative Site, Sao Paulo, São Paulo, Brazil

Novartis Investigative Site, Rio de Janeiro, , Brazil

Novartis Investigative Site, Plovdiv, , Bulgaria

Novartis Investigative Site, Sofia, , Bulgaria

Novartis Investigative Site, Sofia, , Bulgaria

Novartis Investigative Site, Sofia, , Bulgaria

Novartis Investigative Site, Varna, , Bulgaria

Novartis Investigative Site, Calgary, Alberta, Canada

Novartis Investigative Site, Fuzhou, Fujian, China

Novartis Investigative Site, Guangzhou, Guangdong, China

Novartis Investigative Site, Changchun, Jilin, China

Novartis Investigative Site, Harbin, , China

Novartis Investigative Site, Shanghai, , China

Novartis Investigative Site, Monteria, , Colombia

Novartis Investigative Site, Osijek, , Croatia

Novartis Investigative Site, Pula, , Croatia

Novartis Investigative Site, Zagreb, , Croatia

Novartis Investigative Site, Besancon, , France

Novartis Investigative Site, Le Mans, , France

Novartis Investigative Site, Lille, , France

Novartis Investigative Site, Montpellier Cedex 5, , France

Novartis Investigative Site, Nancy, , France

Novartis Investigative Site, Paris Cedex 20, , France

Novartis Investigative Site, Heidelberg, Baden-Wuerttemberg, Germany

Novartis Investigative Site, Tuebingen, Baden-Wuerttemberg, Germany

Novartis Investigative Site, Muenchen, Bayern, Germany

Novartis Investigative Site, Muenchen, Bayern, Germany

Novartis Investigative Site, Regensburg, Bayern, Germany

Novartis Investigative Site, Rosenheim, Bayern, Germany

Novartis Investigative Site, Fuerstenwalde, Brandenburg, Germany

Novartis Investigative Site, Rostock, Mecklenburg-Vorpommern, Germany

Novartis Investigative Site, Goslar, Niedersachsen, Germany

Novartis Investigative Site, Hannover, Niedersachsen, Germany

Novartis Investigative Site, Aachen, Nordrhein-Westfalen, Germany

Novartis Investigative Site, Bottrop, Nordrhein-Westfalen, Germany

Novartis Investigative Site, Troisdorf, Nordrhein-Westfalen, Germany

Novartis Investigative Site, Velbert, Nordrhein-Westfalen, Germany

Novartis Investigative Site, Halle, Sachsen-Anhalt, Germany

Novartis Investigative Site, Kiel, Schleswig-Holstein, Germany

Novartis Investigative Site, Berlin, , Germany

Novartis Investigative Site, Berlin, , Germany

Novartis Investigative Site, Hamburg, , Germany

Novartis Investigative Site, Hamburg, , Germany

Novartis Investigative Site, Hamburg, , Germany

Novartis Investigative Site, Athens, , Greece

Novartis Investigative Site, Chania, , Greece

Novartis Investigative Site, Heraklion, , Greece

Novartis Investigative Site, Perioxi Dragana, Alexandroupolis, , Greece

Novartis Investigative Site, Hong Kong, , Hong Kong

Novartis Investigative Site, Kowloon, , Hong Kong

Novartis Investigative Site, Pokfulam, , Hong Kong

Novartis Investigative Site, Tuen Mun, , Hong Kong

Novartis Investigative Site, Budapest, , Hungary

Novartis Investigative Site, Budapest, , Hungary

Novartis Investigative Site, Debrecen, , Hungary

Novartis Investigative Site, Gyor, , Hungary

Novartis Investigative Site, Gyula, , Hungary

Novartis Investigative Site, Kaposvar, , Hungary

Novartis Investigative Site, Miskolc, , Hungary

Novartis Investigative Site, Nyiregyhaza, , Hungary

Novartis Investigative Site, Pecs, , Hungary

Novartis Investigative Site, Szeged, , Hungary

Novartis Investigative Site, Szolnok, , Hungary

Novartis Investigative Site, Veszprem, , Hungary

Novartis Investigative Site, Zalaegerszeg, , Hungary

Novartis Investigative Site, Bangalore, , India

Novartis Investigative Site, Chennai, , India

Novartis Investigative Site, Delhi, , India

Novartis Investigative Site, Nagpur, , India

Novartis Investigative Site, New Delhi, , India

Novartis Investigative Site, Pune, , India

Novartis Investigative Site, Surat, , India

Novartis Investigative Site, Dublin 7, , Ireland

Novartis Investigative Site, Dublin, , Ireland

Novartis Investigative Site, Dublin, , Ireland

Novartis Investigative Site, Dublin, , Ireland

Novartis Investigative Site, Galway, , Ireland

Novartis Investigative Site, Haifa, , Israel

Novartis Investigative Site, Jerusalem, , Israel

Novartis Investigative Site, Petah-Tikva, , Israel

Novartis Investigative Site, Ramat Gan, , Israel

Novartis Investigative Site, Rehovot, , Israel

Novartis Investigative Site, Tel Aviv, , Israel

Novartis Investigative Site, Parma, Emilia-Romagna, Italy

Novartis Investigative Site, Piacenza, Emilia-Romagna, Italy

Novartis Investigative Site, Monza, Lombardia, Italy

Novartis Investigative Site, Pavia, Lombardia, Italy

Novartis Investigative Site, Rozzano (MI), Lombardia, Italy

Novartis Investigative Site, San Giovanni Rotondo, , Italy

Novartis Investigative Site, Aichi, , Japan

Novartis Investigative Site, Chiba, , Japan

Novartis Investigative Site, Ehime, , Japan

Novartis Investigative Site, Kagoshima, , Japan

Novartis Investigative Site, Osaka, , Japan

Novartis Investigative Site, Osaka, , Japan

Novartis Investigative Site, Saitama, , Japan

Novartis Investigative Site, Saitama, , Japan

Novartis Investigative Site, Shizuoka, , Japan

Novartis Investigative Site, Tokyo, , Japan

Novartis Investigative Site, Tokyo, , Japan

Novartis Investigative Site, Tokyo, , Japan

Novartis Investigative Site, Gyeonggi-do, , Korea, Republic of

Novartis Investigative Site, Seoul, , Korea, Republic of

Novartis Investigative Site, Seoul, , Korea, Republic of

Novartis Investigative Site, Seoul, , Korea, Republic of

Novartis Investigative Site, Vilnius, , Lithuania

Novartis Investigative Site, Lorenskog, , Norway

Novartis Investigative Site, Miraflores, Lima, Peru

Novartis Investigative Site, San Borja, Lima, Peru

Novartis Investigative Site, San Isidro, Lima, Peru

Novartis Investigative Site, Arequipa, , Peru

Novartis Investigative Site, Lima, , Peru

Novartis Investigative Site, Trujillo, , Peru

Novartis Investigative Site, Makati City, , Philippines

Novartis Investigative Site, Quezon City, , Philippines

Novartis Investigative Site, Konin, , Poland

Novartis Investigative Site, Lubin, , Poland

Novartis Investigative Site, Otwock, , Poland

Novartis Investigative Site, Warszawa, , Poland

Novartis Investigative Site, Warszawa, , Poland

Novartis Investigative Site, Wieliszew, , Poland

Novartis Investigative Site, Wroclaw, , Poland

Novartis Investigative Site, Coimbra, , Portugal

Novartis Investigative Site, Evora, , Portugal

Novartis Investigative Site, Lisboa, , Portugal

Novartis Investigative Site, Lisbon, , Portugal

Novartis Investigative Site, Porto, , Portugal

Novartis Investigative Site, San Juan, , Puerto Rico

Novartis Investigative Site, San Juan, , Puerto Rico

Novartis Investigative Site, Bucharest, , Romania

Novartis Investigative Site, Bucuresti, , Romania

Novartis Investigative Site, Timisoara, , Romania

Novartis Investigative Site, Arkhangelsk, , Russian Federation

Novartis Investigative Site, Kazan, , Russian Federation

Novartis Investigative Site, Moscow, , Russian Federation

Novartis Investigative Site, Moscow, , Russian Federation

Novartis Investigative Site, Ryazan, , Russian Federation

Novartis Investigative Site, St. Petersburg, , Russian Federation

Novartis Investigative Site, St. Petersburg, , Russian Federation

Novartis Investigative Site, Tver, , Russian Federation

Novartis Investigative Site, Belgrade, , Serbia

Novartis Investigative Site, Kragujevac, , Serbia

Novartis Investigative Site, Sremska Kamenica, , Serbia

Novartis Investigative Site, Singapore, , Singapore

Novartis Investigative Site, Cape Town, , South Africa

Novartis Investigative Site, Durban, , South Africa

Novartis Investigative Site, Port Elizabeth, , South Africa

Novartis Investigative Site, Pretoria, , South Africa

Novartis Investigative Site, Saxonwold, Johannesburg, , South Africa

Novartis Investigative Site, Barcelona, , Spain

Novartis Investigative Site, Barcelona, , Spain

Novartis Investigative Site, Castellon, , Spain

Novartis Investigative Site, Cordoba, , Spain

Novartis Investigative Site, La Coruna, , Spain

Novartis Investigative Site, Madrid, , Spain

Novartis Investigative Site, Santa Cruz de Tenerife, , Spain

Novartis Investigative Site, Changhua, , Taiwan

Novartis Investigative Site, Kaohsiung Hsien, , Taiwan

Novartis Investigative Site, Taipei City, , Taiwan

Novartis Investigative Site, Ankara, , Turkey

Novartis Investigative Site, Izmir, , Turkey

Novartis Investigative Site, Chernivtsi, , Ukraine

Novartis Investigative Site, Dnipropetrovsk, , Ukraine

Novartis Investigative Site, Kharkiv, , Ukraine

Novartis Investigative Site, Khmelnytskyi, , Ukraine

Novartis Investigative Site, Lyutizh, , Ukraine

Novartis Investigative Site, Sumy, , Ukraine

Novartis Investigative Site, Uzhgorod, , Ukraine

Novartis Investigative Site, Vinnitsia, , Ukraine

Novartis Investigative Site, Chelmsford, Essex, United Kingdom

Novartis Investigative Site, Birmingham, West Midlands, United Kingdom

Novartis Investigative Site, Huddersfield, , United Kingdom

Novartis Investigative Site, London, , United Kingdom

Novartis Investigative Site, London, , United Kingdom

Novartis Investigative Site, Maidstone, , United Kingdom

Novartis Investigative Site, Manchester, , United Kingdom

Novartis Investigative Site, Nottingham, , United Kingdom

Novartis Investigative Site, Peterborough, , United Kingdom

Novartis Investigative Site, Sutton, , United Kingdom

Contact Details

Name: Novartis Pharmaceuticals

Affiliation: Novartis Pharmaceuticals

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: